v3.19.2
Shareholders' equity (deficit) (Tables)
6 Months Ended
Jun. 30, 2019
Shareholders' equity (deficit)  
Schedule of additional paid-in capital

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Three months ended June 30, 

 

Six months ended June 30, 

 

 

2019

    

2018

 

2019

    

2018

Opening balance

 

$

2,840

 

$

2,472

 

$

2,655

 

$

2,372

Share-based compensation expense

 

 

276

 

 

79

 

 

487

 

 

204

Exercise of stock options

 

 

 —

 

 

(7)

 

 

(26)

 

 

(32)

 

 

 

 

 

 

 

 

 

 

 

 

 

Closing balance

 

$

3,116

 

$

2,544

 

$

3,116

 

$

2,544

 

Schedule of outstanding and exercisable options

The total outstanding and exercisable options from the 2011 Plan and 2019 Plan as at June 30 were as follows:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

2019

 

2018

 

 

 

 

Weighted

 

 

 

Weighted

 

 

 

 

average

 

 

 

average

 

 

Number

 

exercise

 

Number

 

exercise

 

    

of shares

    

price

    

of shares

    

price

Outstanding at beginning of period

 

2,295,045

 

$

1.7714

 

968,782

 

$

1.1330

Forfeited/cancelled

 

 —

 

 

 —

 

(12,198)

 

 

1.0958

Granted – 2011 Plan

 

116,739

 

 

9.4152

 

887,432

 

 

1.5400

Granted – 2019 Plan

 

46,998

 

 

15.0000

 

 —

 

 

 —

Exercised

 

(18,153)

 

 

1.3225

 

(42,781)

 

 

0.8298

Outstanding at end of period

 

2,440,629

 

$

2.3963

 

1,801,235

 

$

1.3405

Exercisable at end of period

 

771,478

 

$

1.3777

 

563,565

 

$

1.0266

 

Schedule of non-vested share options activity

The non-vested options as at June 30 were as follows:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

2019

 

2018

 

 

 

 

Weighted

 

 

 

Weighted

 

 

Number

 

average

 

Number

 

average

 

    

of options

    

fair value

    

of options

    

fair value

Non-vested at beginning of period

 

1,706,303

 

$

1.3458

 

451,113

 

$

1.0266

Forfeited/cancelled

 

 —

 

 

 —

 

(12,198)

 

 

1.0639

Granted – 2011 Plan

 

116,739

 

 

6.6491

 

887,432

 

 

1.1114

Granted – 2019 Plan

 

46,998

 

 

10.7731

 

 —

 

 

 —

Vested, outstanding

 

(200,889)

 

 

1.1787

 

(88,600)

 

 

1.0958

Non-vested share options at end of period

 

1,669,151

 

$

2.0041

 

1,237,747

 

$

1.0798

 

Schedule of weighted average assumptions for the options granted

The fair value of options granted was estimated using the Black-Scholes option pricing model, resulting in the following weighted average assumptions for the options granted for the three-month and six-month periods ended June 30:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Three months ended June 30,

 

Six months ended June 30,

 

 

    

2019

    

2018

    

2019

    

2018

 

Exercise price

 

$

12.05

 

$

1.54

 

$

11.02

 

$

1.54

 

Share price

 

$

12.05

 

$

1.54

 

$

11.02

 

$

1.54

 

Volatility

 

 

82

%  

 

82

%  

 

81

%  

 

82

%

Risk-free interest rate

 

 

2.36

%  

 

2.73

%  

 

2.41

%  

 

2.77

%

Expected life

 

 

6.25 years

 

 

6.25 years

 

 

6.25 years

 

 

6.25 years

 

Dividend

 

 

0

%  

 

0

%  

 

0

%  

 

0

%

 

Schedule of share-based compensation expense

The Company recognized share-based compensation expense as follows for the three and six months ended June 30:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Three months ended June 30,

 

Six months ended June 30,

 

    

2019

    

2018

    

2019

    

2018

Administration

 

$

133

 

$

21

 

$

203

 

$

50

Research and development

 

 

109

 

 

49

 

 

234

 

 

125

Commercial activities

 

 

34

 

 

10

 

 

50

 

 

29

 

 

$

276

 

$

80

 

$

487

 

$

204